BNB Plus (BNBX)
NASDAQ:BNBX
Want to see BNBX full AI Analyst Report?
BNBX Stock Chart & Stats
$1.48
--
Market closed
$1.48
--
Day’s Range― - ―
52-Week Range$0.45 - $12.75
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.96M
Market Cap
$2.75M
Enterprise Value-$1.78M
Total Cash (Recent Filing)$2.45M
Total Debt (Recent Filing)$48.86K
Price to Earnings (P/E)―
Beta2.62
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-269.50
Shares Outstanding5,667,469
10 Day Avg. Volume46,292
30 Day Avg. Volume1,955,224
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.87
Price to Sales (P/S)0.94
P/FCF Ratio-0.16
Enterprise Value/Market Cap-0.65
Enterprise Value/Revenue-0.86
Enterprise Value/Gross Profit-3.74
Enterprise Value/Ebitda0.07
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-82.5
Revenue Forecast (FY)$7.40M
Bulls Say, Bears Say
Bulls Say
Very Low LeverageExtremely low reported debt materially reduces refinancing and solvency risk over the next several months. That balance-sheet conservatism preserves financial optionality, giving management time to pursue strategic fixes or raise capital on more favorable terms if operating losses persist.
Positive Gross MarginA positive gross margin indicates the core product/service generates more than its direct costs, providing a structural base for margin recovery if revenue stabilizes. With disciplined cost control and scale, this product-level profitability could support a return to operating leverage over months.
Board Granted Reverse-split AuthorityShareholder approval gives management a concrete corporate-governance tool to restructure capital and pursue listing-compliance remedies. This structural authority can be used to address Nasdaq standards and improve per-share metrics, helping preserve listing and institutional access if executed prudently.
Bears Say
Declining RevenueSustained revenue decline erodes scale and amplifies the fixed-cost burden, making margin recovery harder and extending the timeline to break even. Continued top-line contraction increases reliance on external funding and raises the structural risk of further cost-cutting or strategic pivots.
Persistent Cash BurnMaterial negative operating and free cash flows indicate ongoing cash consumption that will deplete resources without financing or rapid operational improvement. Over a multi-month horizon this necessitates external capital, which risks dilution or constrained strategic options if markets or listing status are impaired.
Nasdaq Delisting RiskA formal Nasdaq notice creates structural uncertainty around listing and liquidity. Delisting would reduce institutional participation and access to capital, and even the hearing process can limit financing alternatives and strategic partnerships until compliance is demonstrably restored.
BNB Plus News
BNBX FAQ
What was BNB Plus’s price range in the past 12 months?
BNB Plus lowest stock price was $0.45 and its highest was $12.75 in the past 12 months.
What is BNB Plus’s market cap?
BNB Plus’s market cap is $2.75M.
When is BNB Plus’s upcoming earnings report date?
BNB Plus’s upcoming earnings report date is Aug 06, 2026 which is in 86 days.
How were BNB Plus’s earnings last quarter?
Currently, no data Available
Is BNB Plus overvalued?
According to Wall Street analysts BNB Plus’s price is currently Overvalued.
Does BNB Plus pay dividends?
BNB Plus does not currently pay dividends.
What is BNB Plus’s EPS estimate?
BNB Plus’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BNB Plus have?
BNB Plus has 5,667,469 shares outstanding.
What happened to BNB Plus’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BNB Plus?
Currently, no hedge funds are holding shares in BNBX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
BNB Plus
BNB Plus Corp. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through the following segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment consists of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. The MDx Testing Services segment develops clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment is involved in the detection of DNA for industrial supply chains and security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.
Technical Analysis
ENDRA Life Sciences
―
Intelligent Bio Solutions
―
iSpecimen
―
BioNexus Gene Lab Corp
―
―
Ownership Overview
2.98% Insiders
0.52% Mutual Funds
<0.01% Other Institutional Investors
96.49% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---